• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug - pp493 - 502

Renaud Capdeville, Elisabeth Buchdunger, Juerg Zimmermann & Alex Matter

doi:10.1038/nrd839

• Abstract
• Full Text
• PDF (1,062 KB)

Nucleic-acid therapeutics: basic principles and recent applications - pp503 - 514

Joanna B. Opalinska & Alan M. Gewirtz

doi:10.1038/nrd837

• Abstract
• Full Text
• PDF (331 KB)

Optical biosensors in drug discovery - pp515 - 528

Matthew A. Cooper

doi:10.1038/nrd838

• Abstract
• Full Text
• PDF (1,164 KB)
• Supplementary information

New horizons — alternative routes for insulin therapy - pp529 - 540

David R. Owens

doi:10.1038/nrd836

• Abstract
• Full Text
• PDF (1,057 KB)

Genome-based pharmacogenetics and the pharmaceutical industry - pp541 - 549

Allen D. Roses

doi:10.1038/nrd840

• Abstract
• Full Text
• PDF (609 KB)